Status:
UNKNOWN
Hepatocellular Research Registry
Lead Sponsor:
Vanderbilt University
Conditions:
Hepatocytes
Eligibility:
All Genders
18+ years
Brief Summary
This is a registry of human hepatocytes (liver cells) for research purposes.
Detailed Description
Patients scheduled for partial hepatectomy/liver surgery are asked permission to use their discarded liver tissue for purposes of studying: 1. how drugs/medicines affect the liver and 2. the effects ...
Eligibility Criteria
Inclusion
- Persons undergoing partial hepatectomy/liver surgery for any reason.
Exclusion
- Persons with known HIV, hepatitis B virus (HBV), or hepatitis C virus (HCV)
- A diagnosis of hepatocellular carcinoma without negative serologies
- A diagnosis of cholangiocarcinoma, where the total bilirubin has ever been greater or equal to 3.0
- The presence of a biliary drainage tube
- Active sepsis
Key Trial Info
Start Date :
April 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00178893
Start Date
April 1 2004
End Date
December 1 2022
Last Update
April 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University
Nashville, Tennessee, United States, 37232-4753